US Stock MarketDetailed Quotes

TNXP Tonix Pharmaceuticals

Watchlist

0.5270
-0.0408-7.19%

Close Jul 24 16:00 ET

0.5477
+0.0207+3.93%

Post 19:28 ET

9.20MMarket Cap-4P/E (TTM)

Tonix Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Total revenue

2.48M

7.77M

3.78M

3.99M

Operating revenue

--2.48M

--7.77M

--3.78M

--3.99M

--0

Cost of revenue

1.66M

4.74M

2.37M

Gross profit

822K

3.03M

1.41M

1.62M

Operating expense

-34.60%22.17M

8.31%121.41M

-12.18%28.74M

0.58%29.76M

24.28%29M

28.24%33.9M

21.43%112.09M

11.02%32.73M

59.65%29.59M

-0.96%23.34M

Selling and administrative expenses

25.96%9.31M

15.02%34.75M

44.29%11.62M

17.89%8.71M

3.98%7.03M

-7.77%7.39M

28.72%30.22M

12.13%8.05M

35.52%7.39M

24.46%6.76M

-General and administrative expense

25.96%9.31M

15.02%34.75M

----

3.98%7.03M

-7.77%7.39M

28.72%30.22M

----

24.46%6.76M

Research and development costs

-51.48%12.86M

5.84%86.66M

-30.62%17.12M

-5.18%21.05M

32.55%21.98M

43.91%26.51M

18.94%81.88M

10.67%24.67M

69.71%22.2M

-8.57%16.58M

Operating profit

37.02%-21.35M

-5.61%-118.38M

16.50%-27.33M

4.88%-28.15M

-24.28%-29M

-28.24%-33.9M

-21.43%-112.09M

-11.02%-32.73M

-59.65%-29.59M

0.96%-23.34M

Net non-operating interest income expense

-71.80%172K

229.59%646K

8,614.29%610K

2,077.78%196K

Non-operating interest income

----

-71.80%172K

229.59%646K

----

8,614.29%610K

2,077.78%196K

Other net income (expense)

614.83%6.41M

-8.06%1.72M

897K

1.87M

Gain on sale of security

--7.01M

----

Other non- operating income (expenses)

-166.11%-593K

-8.06%1.72M

----

--897K

--1.87M

----

Income before tax

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

1.75%-23.14M

Income tax

Net income

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

1.75%-23.14M

Net income continuous Operations

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

1.75%-23.14M

Minority interest income

Net income attributable to the parent company

54.74%-14.94M

-5.84%-116.66M

13.76%-27.32M

3.47%-27.98M

-22.54%-28.36M

-24.94%-33.01M

-19.43%-110.22M

-7.20%-31.68M

-56.42%-28.98M

1.75%-23.14M

Preferred stock dividends

6.66M

2.4M

4.26M

Other preferred stock dividends

Net income attributable to common stockholders

54.74%-14.94M

0.19%-116.66M

19.84%-27.32M

3.47%-27.98M

-3.51%-28.36M

-24.94%-33.01M

-26.65%-116.88M

-15.33%-34.08M

-56.42%-28.98M

-16.31%-27.4M

Basic earnings per share

94.39%-5.76

65.77%-219.2

86.68%-14.9161

56.84%-58.56

64.92%-85.76

68.10%-102.72

60.47%-640.32

75.00%-112

57.60%-135.68

45.67%-244.48

Diluted earnings per share

94.39%-5.76

65.77%-219.2

86.68%-14.9161

56.84%-58.56

64.92%-85.76

68.10%-102.72

60.47%-640.32

75.00%-112

57.60%-135.68

45.67%-244.48

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Total revenue	2.48M	7.77M	3.78M	3.99M	0	0	0	0	0	0
Operating revenue	--2.48M	--7.77M	--3.78M	--3.99M	--0	--0	--0	--0	--0	--0
Cost of revenue	1.66M	4.74M	2.37M	2.37M		0	0	0	0
Gross profit	822K	3.03M	1.41M	1.62M		0	0	0	0
Operating expense	-34.60%22.17M	8.31%121.41M	-12.18%28.74M	0.58%29.76M	24.28%29M	28.24%33.9M	21.43%112.09M	11.02%32.73M	59.65%29.59M	-0.96%23.34M
Selling and administrative expenses	25.96%9.31M	15.02%34.75M	44.29%11.62M	17.89%8.71M	3.98%7.03M	-7.77%7.39M	28.72%30.22M	12.13%8.05M	35.52%7.39M	24.46%6.76M
-General and administrative expense	25.96%9.31M	15.02%34.75M	----	----	3.98%7.03M	-7.77%7.39M	28.72%30.22M	----	----	24.46%6.76M
Research and development costs	-51.48%12.86M	5.84%86.66M	-30.62%17.12M	-5.18%21.05M	32.55%21.98M	43.91%26.51M	18.94%81.88M	10.67%24.67M	69.71%22.2M	-8.57%16.58M
Operating profit	37.02%-21.35M	-5.61%-118.38M	16.50%-27.33M	4.88%-28.15M	-24.28%-29M	-28.24%-33.9M	-21.43%-112.09M	-11.02%-32.73M	-59.65%-29.59M	0.96%-23.34M
Net non-operating interest income expense				-71.80%172K	229.59%646K				8,614.29%610K	2,077.78%196K
Non-operating interest income	----	----	----	-71.80%172K	229.59%646K	----	----	----	8,614.29%610K	2,077.78%196K
Other net income (expense)	614.83%6.41M	-8.06%1.72M				897K	1.87M
Gain on sale of security	--7.01M	----	----	----	----	----	----	----	----	----
Other non- operating income (expenses)	-166.11%-593K	-8.06%1.72M	----	----	----	--897K	--1.87M	----	----	----
Income before tax	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M	1.75%-23.14M
Income tax
Net income	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M	1.75%-23.14M
Net income continuous Operations	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M	1.75%-23.14M
Minority interest income
Net income attributable to the parent company	54.74%-14.94M	-5.84%-116.66M	13.76%-27.32M	3.47%-27.98M	-22.54%-28.36M	-24.94%-33.01M	-19.43%-110.22M	-7.20%-31.68M	-56.42%-28.98M	1.75%-23.14M
Preferred stock dividends							6.66M	2.4M		4.26M
Other preferred stock dividends
Net income attributable to common stockholders	54.74%-14.94M	0.19%-116.66M	19.84%-27.32M	3.47%-27.98M	-3.51%-28.36M	-24.94%-33.01M	-26.65%-116.88M	-15.33%-34.08M	-56.42%-28.98M	-16.31%-27.4M
Basic earnings per share	94.39%-5.76	65.77%-219.2	86.68%-14.9161	56.84%-58.56	64.92%-85.76	68.10%-102.72	60.47%-640.32	75.00%-112	57.60%-135.68	45.67%-244.48
Diluted earnings per share	94.39%-5.76	65.77%-219.2	86.68%-14.9161	56.84%-58.56	64.92%-85.76	68.10%-102.72	60.47%-640.32	75.00%-112	57.60%-135.68	45.67%-244.48
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall